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Abstract
Background: Vancomycin-resistant Enterococcus faecium ventriculitis is one of the most severe events in
postneurosurgical intracranial infections. There are no guidelines recommending an appropriate treatment before.
Case presentation: This case presents a successful linezolid treatment for post-neurosurgical vancomycin-resistant
Enterococcus faecium ventriculitis of a 24-year-old man in the department of neurosurgery, Beijing Tiantan Hospital.
Conclusions: Linezolid should be considered as one of the important methods for the treatment of post-
neurosurgical intracranial infections caused by vancomycin-resistant Enterococcus.
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Background
Hospital acquired infection is a tough medical problem
existing in many medical treatments. The most common
causes are surgical-site-related, catheter-related, and
ventilator-associated infections. Some of them may lead to
severe results. Neurosurgical site infection often appears as
meningitis or ventriculitis, which are considered critical in-
fectious diseases and may lead to the death of the patient.
Nosocomially acquired intracranial infections may be caused
by a wide array of microorganisms, including staphylococci,
enterococci, Gram-negative bacilli and yeasts. However the
pathogen such as vancomycin-resistant Enterococcus (VRE) is
very rare in intracranial infections. We report a successful case
of linezolid treatment for post-neurosurgical vancomycin-
resistant Enterococcus faecium ventriculitis.
Case presentation
A 24-year-old man who had presented with diplopia,
headache, right side myasthenia and bucking
symptoms, was admitted to Beijing Tiantan Hospital
for treatment. The MRI revealed a suprasellar cistern
tumor. Then he underwent right frontotemporal-
orbitozygomatic approach craniotomy for the supra-
sellar cistern tumor resection. The pathology of
tumor was notochordoma. One week after the oper-
ation, the CSF leakage appeared. So the patient
underwent the second operation to repair the CSF
leakage and also got the lumbar cistern drainage.
After the surgical intervention, the patient developed
a middle-grade fever and altered consciousness. The
white blood cell count rose up, so the antimicrobial
treatment was initialized with Ceftazidime, Piperacil-
lin and Sulbactam. There is no sign of infection im-
provement. The body temperature of the patient
kept between 38 °C to 39 °C. And the white blood
cell count kept between 12 × 109/L and 18 × 109/L.
The conscious state of the patient worsened day by
day. Twenty days later, the patient developed acute
hydrocephalus and brain hernia. The lateral ventricu-
lar puncture external drainage was performed imme-
diately. It helped the patient to recover form coma.
However the ventriculitis appeared. The cerebro-
spinal fluid (CSF) obtained from lateral ventricular
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puncture external drainage was yellow, turbidity and
flocculent. And the white blood cell count of CSF
rose up to more than 2000/μL. The antimicrobial
treatment changed to amikacin, meropenem and
vancomycin for ten days. Later the vancomycin-
resistant Enterococcus (VRE) faecium was isolated
from the CSF culture. It was resistant to vancomycin
and imipenem, but sensitive to linezolid (LZD). Thus
linezolid was administrated intravenously 600 mg
q12h for half a month. It resulted in a resolution of
the ventriculitis and a negative CSF culture. The fol-
lowing occipital ventriculoperitoneal shunt procedure
resulted in a cure Figs. 1, 2, 3 and 4 (Table 1).
Discussion
Nosocomial infections are important medical problems
in neurosurgical patients. Among the nosocomial infec-
tions, meningitis and ventriculitis are fearful infections
and can lead to severe complications even death. The re-
ported incidence of postoperative meningitis is quite
variable (0.5 – 8 %) [1–5]. The incidence of ventriculitis
is even lower.
Post-neurosurgical intracranial infections are mostly
caused by a wide array of microorganisms. It is reported
that the most common organisms causing meningitis are
non-fermentative Gram-negative bacteria (NFGNB)
(27.3 %), followed by Pseudomonas aeruginosa (15.6 %)
and Klebsiella species (12.6 %). A study of 18092 pa-
tients who underwent neurosurgical procedures at the
department of neurosurgery, National Institute of Mental
Health and Neurological Sciences, Bangalore, India during
2001 to 2007, showed that 415 patients developed infection
such as meningitis. Only 9 patients of them developed to
enterococcus meningitis [6]. Vancomycin-resistant Entero-
coccus (VRE) ventriculitis occurs extremely rare. So far
there are no guidelines recommending an appropriate
treatment.
Linezolid (LZD) is the first licensed member of the
oxazolidinone class of antibiotics. It has good activity
against almost all Gram-positive pathogens, including
multidrug-resistant organisms such as methicillin-resistant
Staphylococcus aureus (MRSA) and vancomycin-resistant
Enterococcus (VRE) faecium [7]. The unique mechanism
Fig. 1 Preoperative CT and MRI without contrast of the brain reveals a suprasellar cistern tumor
Table 1 Susceptibility results of the pathogen vancomycin-
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of linezolid, that involves inhibition of bacterial protein
synthesis at a very early stage of the process, makes
cross-resistance between linezolid and other classes of
antibacterial agents unlikely [8]. Excellent tissue pene-
tration and great oral bioavailability are notable prop-
erties of linezolid. Thus it allows sequential
intravenous-to-oral administration without changing
the drug or dosage regimen. It is approved in Europe
and the USA for the treatment of nosocomial pneu-
monia, skin and soft tissue infections; and in the USA
vancomycin-resistant Enterococcus (VRE) faecium and
methicillin-resistant Staphylococcus aureus (MRSA)
infections [9]. Linezolid is reported to have good
penetration into the CNS [10]. A study in Japan
showed the penetration of LZD into the CSF was
58.9 % of the peak value and 133 % of the trough
value of serum concentrations following intravenous
administration. And the penetration of LZD into the
CSF was 82.9 % of the peak value and 145.6 % of the
trough value of serum concentrations following oral
administration [11]. For patients with a range of
serious Gram-positive infections, including those
caused by suspected or proven multidrug-resistant
pathogens such as VRE or MRSA, linezolid can be an
effective and generally well tolerated therapeutic op-
tion. In spite of this, gastrointestinal adverse effects
are relatively common with linezolid and also associ-
ated with thrombocytopenia and myelosuppression
[7]. Thus if the adverse effects occur, the doses and
treatment period should be reduced.
In this case, the pathogen caused ventriculitis of the
patient was vancomycin-resistant Enterococcus (VRE)
faecium. It was resistant to many antimicrobials but
sensitive to LZD. LZD administrated intravenously
600 mg q12h for half a month, followed by lumbar cis-
tern drainage and VP shunt, led to an excellent out-
come. Post-neurosurgical intracranial infections are
critical severe events. The appropriate use of antibi-
otics is a key point. The antibiotics should be sensitive
to pathogens and have good penetration into the CNS.
The appropriate neurosurgical intervention is also very
important, such as lateral ventricular puncture external
Fig. 3 Postoperative CT reveals the appearance of ventriculitis and the performance of lateral ventricular puncture external drainage
Fig. 2 Postoperative CT reveals the tumor removal but hydrocephalus 20 days after the second operation
Qiu et al. Chinese Neurosurgical Journal  (2015) 1:18 Page 3 of 4
drainage, lumbar cistern drainage, and VP shunt. Mul-
tiple methods led to the cure of post-neurosurgical
vancomycin-resistant Enterococcus faecium ventriculi-
tis in this case.
Conclusion
LZD should be considered as one of the important
methods for the treatment of post-neurosurgical intra-
cranial infections caused by vancomycin-resistant
Enterococcus.
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Fig. 4 Postoperative CT reveals the resolution of the ventriculitis and hydrocephalus, after the use of linezolid and the ventriculoperitoneal
shunt procedure
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